Digital PCR

Nanoplate dPCR workflow

Simplifying going digital

Yes, in just 3 simple steps you can have the result you want in under 2 hours: pipette and load, let the experiment run, analyze results.

We’re committed to simplifying the workflow so that you can benefit from this technology in more ways than one.

A simple and rapid plate-based workflow

Just like in qPCR experiments, sample preparation includes the transfer of master mix, probes and primers to a 96- or 24-well nanoplate, followed by the addition of samples. The system integrates partitioning, thermocycling and imaging into a single fully automated instrument that takes users from the sample to result in under 2 hours. One can perform analysis on the Software Suite, providing the concentration in copies per microliter of your target sequence as well as for quality control such as positive samples or NTC. This analysis can also be extended to remote computers within the same local area network (LAN).

Have we triggered your interest?

This interactive demo illustrates the complete process step-by-step.

Front-end automation on the QIAgility

To overcome potential pipetting mistakes in setting up the QIAcuity Nanoplates for dPCR analysis, we developed a method for the front-end automation of nanoplate setup using the QIAgility liquid handling instrument.

Two is better than one

Have you considered the power of two for your cancer research workflow? Discover how you can achieve a high level of standardization for liquid biopsy samples and gain maximum convenience for FFPE samples by combining high-volume sample processing on the EZ2 Connect. Connect with fast and sensitive ultra-low mutation detection using digital PCR on the QIAcuity.

Faster and more scalable digital PCR
Learn more about the features and specifications of QIAcuity, and find the right configuration for your lab.
The QIAcuity is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease. Therefore, the performance characteristics of the product for clinical use (i.e., diagnostic, prognostic, therapeutic or blood banking) is unknown.